By
Vish Srivastava2025-10-20T09:00:00
Vish Srivastava considers the benefits of expanding the role of real-world data in drug discovery to provide improved therapies, faster and with greater success.
Already a member? Sign in
By highlighting cutting-edge research and its practical applications, Drug Target Review enables readers to make decisions that accelerate innovation, translate discoveries into therapies, and create tangible benefits for patients worldwide.
By becoming a member you join a connected and collaborative community driving the industry forward. Member benefits include:
2026-07-10T09:00:00Z
2026-07-10T06:15:00Z
Contributor Professor Donald E Ingber, By Drug Target Review
2026-07-08T12:00:00Z
2026-07-08T09:00:00Z
2023-03-07T10:55:58
Sponsored by Agilent
2023-11-20T13:43:43
Sponsored by Merck
2023-09-27T13:56:39
Sponsored by Euretos
2024-03-08T10:00:25
Sponsored by Molecular Devices
2023-07-04T09:00:08
Sponsored by SB Drug Discovery
2024-05-10T11:23:31
Sponsored by BellBrook Labs
Site powered by Webvision Cloud